<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01299402</url>
  </required_header>
  <id_info>
    <org_study_id>Adaptogen Study 002</org_study_id>
    <nct_id>NCT01299402</nct_id>
  </id_info>
  <brief_title>A Study on the Effects of Soulera Herbal Blend Intake on Chronic Stress in Healthy Adults</brief_title>
  <official_title>A Pilot Double-Blind Crossover Study on the Effects of Soulera Herbal Blend Intake on Chronic Stress and Its Biomarkers in Healthy Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Joseph Pergolizzi, MD</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>LeraPharm Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>NEMA Research, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study was designed to evaluate the efficacy and safety of Soulera herbal
      mix in powder form and its effects on anxiety and the biomarkers for chronic stress.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Financial Reasons
  </why_stopped>
  <start_date>August 2011</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Salivary Cortisol Levels</measure>
    <time_frame>14 Weeks</time_frame>
    <description>Change in salivary cortisol as stress biomarkers for the chronic stress response following Soulera Herbal Blend intake</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in chronic stress</measure>
    <time_frame>6 times during 14 weeks</time_frame>
    <description>The State-Trait Anxiety Test will be given to measure the change in both chronic stress and anxiety.(</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Questionaire</measure>
    <time_frame>6 times during 14 weeks</time_frame>
    <description>A survery to measure your quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spot Urine Potassium Test</measure>
    <time_frame>6 times during 14 weeks</time_frame>
    <description>A spot urine test will be conducted to determine potassium level. Only the potassium will be measured in the urine.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Chronic Stress</condition>
  <arm_group>
    <arm_group_label>Soulera Herbal Blend</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Blend</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Soulera Herbal Blend</intervention_name>
    <description>This a powder blend of various reputed adaptogenic herbs. The dosage will be one 8.6 gram powder sachet daily.</description>
    <arm_group_label>Soulera Herbal Blend</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>The placebo will be a similar tasting and looking powder blend as the Soulera Herbal Blend. The dosage will be 8.6 grams per sachet daily.</description>
    <arm_group_label>Placebo Blend</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy men and women between the ages of 21-65.

          -  No concerns that would confound the study as determined by study physicians.

          -  Women must not be pregnant or become pregnant for the duration of the study.

        Exclusion Criteria:

          -  The subject has a history of hypersensitivity to any of the compounds used in the
             study

          -  The subject is pregnant or breast feeding. Note: If the potential subject is a
             post-menarche female, a urine pregnancy test must be performed within 24 hours prior
             to study drug administration and confirmed negative in order for the potential subject
             to eb enrolled.

          -  History of Psychiatric Illness or Chronic Stress or Anxiety

          -  Hypertension, cardiovascular disease, liver, hypokalemia, or kidney disease or other
             health concerns that the study physician feels may confound study results

          -  Individuals who are cognitively impaired or who are not able to give informed consent

          -  Any routine prescription medication that the study physician feels may cause drug
             interaction with Soulera or alter the prescription medications' activity

          -  Previous participation in a clinical research trial within 30 days prior to
             randomization

          -  The subject has an ongoing abuse of illicit substances, alcohol, or actively smoking
             marijuana

          -  The subject uses or has used in the past 30 days any steroid formulation, be it
             topical like face cream, ocular as in an eye drop, nasal as in a spray, injection or
             pill.

          -  The subject is a current smoker or uses tobacco products such as chewing tobacco.

          -  The subject is actively engaging in the use of Herbal Medicine, Traditional Chinese
             Medicine, Ancient Indian Medicine, Yoga, or Ayurveda

          -  The subject is a night-shift worker and therefore presumably has an altered cortisol
             diurnal rhythm and is also unable to comply with the required cortisol collection
             times of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph V Pergolizzi, Jr., M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>NEMA Research, Inc.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Taylor Jr., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>NEMA Research, Inc.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ismail Shalaby, M.D., Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>NEMA Research, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NEMA Research, Inc.</name>
      <address>
        <city>Naples</city>
        <state>Florida</state>
        <zip>34108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.nemaresearch.com</url>
  </link>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2011</study_first_submitted>
  <study_first_submitted_qc>February 16, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 18, 2011</study_first_posted>
  <last_update_submitted>September 30, 2012</last_update_submitted>
  <last_update_submitted_qc>September 30, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 2, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>NEMA Research, Inc.</investigator_affiliation>
    <investigator_full_name>Joseph Pergolizzi, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

